Automated Antimicrobial Susceptibility Testing Market, By Product Type (Consumables and Instruments), By Detection Method (Turbidimetric and Colorimetric), By Application (Antibacterial (Tuberculosis and Sepsis), Antifungal, Anti-parasitic, and Anti-viral), By End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Hospitals, and Pathology/Diagnostic Laboratories), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Size, Share, Outlook, and Opportunity Analysis, 2018-2026

  • Published On : May 2019 |
  • Pages : 200 Pages |
  • Format : CMI Insight PPT Format CMI Insight PDF Format

Automated Antimicrobial Susceptibility Testing Market – Insights

Automated antimicrobial susceptibility testing is extensively used to achieve minimum inhibitory concentration (MIC) results using an antimicrobial susceptibility testing system, which offers flexible, customizable testing options to accommodate laboratories of all sizes. Antimicrobial susceptibility testing (AST) aims to ensure that suitable antibiotics are prescribed to individuals by monitoring inhibition zone of antibiotics and emergence of resistant pathogens in infected individuals. Information on local patterns of antimicrobial susceptibility can be collected using antimicrobial susceptibility testing, so that policies guiding the therapy can be based on current data on local resistance trends or institutional antibiogram.

The global automated antimicrobial susceptibility testing market size was valued at US$ 1,295.5 million in 2018 and is expected to witness a CAGR of 8.9% over the forecast period (2018 – 2026).

Global Automated Antimicrobial Susceptibility Testing Market Share (%) Analysis, By Product Type, 2018

Automated Antimicrobial Susceptibility Testing  | Coherent Market Insights

Source: Coherent Market Insights Analysis (2019)

Emergence of multidrug resistance worldwide is expected to drive growth of the automated antimicrobial susceptibility testing market

Increasing number of multidrug resistance cases in tuberculosis (TB), malaria, HIV, influenza, and others among the global population is expected to result in increasing adoption of antimicrobial susceptibility testing to reduce the resistance exposure during the forecast period. For instance, according to the World Health Organization (WHO), in 2014, there were around 480,000 new cases of multidrug-resistant tuberculosis (MDR-TB), a form of tuberculosis that is resistant to the two most powerful anti-TB drugs. Among these, only around 123,000 cases were detected and reported.

Moreover, increasing number of product launches is also expected to highly contribute to the automated antimicrobial susceptibility testing market growth. For instance, in March 2016, Becton, Dickinson and Company launched the new BD Phoenix M50 ID/AST system, which helps to deliver the same rapid, accurate, and cost-effective testing as the legacy BD Phoenix 100, within a small footprint.

Automated Antimicrobial Susceptibility Testing Market - Restraints

Challenges in automated antimicrobial susceptibility testing include stringent rules and regulations from regulatory bodies, which hinders growth of the automated antimicrobial susceptibility testing market size. For instance, in the European Union, antimicrobial susceptibility testing (AST) systems are regulated by the Directive 98/79/EC (IVD directive), which was changed in 2017 with the introduction of the Regulation 2017/746 of the European Parliament and of the Council. It requires design, development, and manufacturing to be performed under a quality system according to ISO 13485.

Automated Antimicrobial Susceptibility Testing Market - Regional Insights

On the basis of region, the global automated antimicrobial susceptibility testing market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is expected to hold a dominant position in the global automated antimicrobial susceptibility testing market during the forecast period, owing to development of new antimicrobial testing procedures and increasing awareness among people regarding antimicrobial resistance (AMR). For instance, in April 2018, the U.S. Food and Drug Administration approved Thermo Scientific Sensititre ID/AST System, the first to offer delafloxacin and meropenem/vaborbactam on IVD-labeled, microbroth dilution susceptibility plates. The antimicrobials are currently available in the U.S. on Sensititre custom plates and are expected be available soon in new standard formats.

Asia Pacific is expected to witness rapid growth in the automated antimicrobial susceptibility testing market, owing to high prevalence of microbial infections and increasing consumption of antibiotics, eventually developing resistance among the population. For instance, according to a 2014 WHO report, multidrug-resistant tuberculosis rates were high in India, especially among those who were previously treated and treatment for the disease is generally limited.

Global Automated Antimicrobial Susceptibility Testing Market Value (US$ Mn) & Y-o-Y Growth (%), 2016-2026

   Automated Antimicrobial Susceptibility Testing  | Coherent Market Insights

 Source: Coherent Market Insights Analysis (2019)

Automated Antimicrobial Susceptibility Testing Market - Competitive Landscape

Key players operating in the global automated antimicrobial susceptibility testing market include bioMérieux S.A., HiMedia Laboratories, Alifax Holding S.p.A., Creative Diagnostics, Resistell AG, Danaher Corporation, Becton, Dickinson and Company, Thermo Fisher Scientific Inc., Merck KGaA, and Bio-Rad Laboratories, Inc.

Automated antimicrobial susceptibility testing products are of two types, consumables and instruments. Consumables used in automated antimicrobial susceptibility testing includes culture & growth media, ready-to-use reagents, complete reagent kits, susceptibility disks, susceptibility plates, and susceptibility cards, among others. Key players offer reagent kits and disposables, which are designed for use with their automated AST instruments, which optimizes workflow and overall laboratory efficiency. Automated microbial identification and antimicrobial susceptibility testing (AST) instruments offer rapid, accurate, and efficient susceptibility testing, thereby enhancing workflow, reducing hands-on time, and enabling rapid reporting. Automated laboratory AST instruments are equipped with Laboratory Information System (LIS) compatible software to enable better compatibility.

Market Dynamics

Increasing prevalence of antibiotic resistance worldwide is expected to boost the automated antimicrobial susceptibility testing market growth. According to the World Health Organization’s Global Antimicrobial Surveillance System (GLASS) report of January 2018, antibiotic resistance is found among 500,000 people with suspected bacterial infections across 22 countries. The most commonly reported resistant bacteria were Escherichia coli, Klebsiella pneumoniae, Staphylococcus aureus, and Streptococcus pneumoniae, followed by Salmonella sp.

However, the major restraining factor affecting growth of the automated antimicrobial susceptibility testing market is the product recalls of instruments for failures or for various other reasons. For instance, in 2016, bioMérieux S.A.’s VITEK 2 Gram Positive Susceptibility Test Cards were recalled by the Food and Drug Administration (FDA), as the product could lead to false susceptible results of Staphylococcus spp., Enterococcus spp., and S. agalactiae. This product was terminated in May 2017.

Key features of the study:

  • This report provides in-depth analysis of the automated antimicrobial susceptibility testing market, market size (US$ Mn), and compound annual growth rate (CAGR (%)) for the forecast period: 2018 – 2026, considering 2017 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
  • It profiles key players in the global automated antimicrobial susceptibility testing market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
  • Key players covered as a part of this study include bioMérieux S.A., HiMedia Laboratories, Alifax Holding S.p.A., Creative Diagnostics, Resistell AG, Danaher Corporation, Becton, Dickinson and Company, Thermo Fisher Scientific Inc., Merck KGaA, and Bio-Rad Laboratories, Inc.
  • Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
  • The global automated antimicrobial susceptibility testing market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, suppliers, research and consulting firms, new entrants, and financial analysts

 

Detailed Segmentation:

  • Global Automated Antimicrobial Susceptibility Testing Market, By Product Type:
    • Consumables
    • Instruments
  • Global Automated Antimicrobial Susceptibility Testing Market, By Detection Method:
    • Turbidimetric
    • Colorimetric
  • Global Automated Antimicrobial Susceptibility Testing Market, By Application:
    • Antibacterial
      • Tuberculosis
      • Sepsis
    • Antifungal
    • Anti-parasitic
    • Anti-viral
  • Global Automated Antimicrobial Susceptibility Testing Market, By End User:
    • Pharmaceutical and Biotechnology Companies
    • Contract Research Organizations
    • Hospitals
    • Pathology/Diagnostic Laboratories
  • Global Automated Antimicrobial Susceptibility Testing Market, By Region:
    • North America
      • By Country:
        • U.S.
        • Canada
      • By Product Type:
        • Consumables
        • Instruments    
      • By Detection Method:
        • Turbidimetric
        • Colorimetric
      • By Application:
        • Antibacterial
          • Tuberculosis
          • Sepsis
        • Antifungal
        • Anti-parasitic
        • Anti-viral
      • By End User:
        • Pharmaceutical and Biotechnology Companies
        • Contract Research Organizations
        • Hospitals
        • Pathology/Diagnostic Laboratories
    • Europe
      • By Country:
        • U.K.
        • Germany
        • Italy
        • Spain
        • France
        • Russia
        • Rest of Europe
      • By Product Type:
        • Consumables
        • Instruments    
      • By Detection Method:
        • Turbidimetric
        • Colorimetric
      • By Application:
        • Antibacterial
          • Tuberculosis
          • Sepsis
        • Antifungal
        • Anti-parasitic
        • Anti-viral
      • By End User:
        • Pharmaceutical and Biotechnology Companies
        • Contract Research Organizations
        • Hospitals
        • Pathology/Diagnostic Laboratories
    • Asia Pacific
      • By Country:
        • Australia
        • India
        • China
        • Japan
        • ASEAN
        • South Korea
        • Rest of Asia Pacific
      • By Product Type:
        • Consumables
        • Instruments    
      • By Detection Method:
        • Turbidimetric
        • Colorimetric
      • By Application:
        • Antibacterial
          • Tuberculosis
          • Sepsis
        • Antifungal
        • Anti-parasitic
        • Anti-viral
      • By End User:
        • Pharmaceutical and Biotechnology Companies
        • Contract Research Organizations
        • Hospitals
        • Pathology/Diagnostic Laboratories
    • Latin America
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
      • By Product Type:
        • Consumables
        • Instruments    
      • By Detection Method:
        • Turbidimetric
        • Colorimetric
      • By Application:
        • Antibacterial
          • Tuberculosis
          • Sepsis
        • Antifungal
        • Anti-parasitic
        • Anti-viral
      • By End User:
        • Pharmaceutical and Biotechnology Companies
        • Contract Research Organizations
        • Hospitals
        • Pathology/Diagnostic Laboratories
    • Middle East
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
      • By Product Type:
        • Consumables
        • Instruments    
      • By Detection Method:
        • Turbidimetric
        • Colorimetric
      • By Application:
        • Antibacterial
          • Tuberculosis
          • Sepsis
        • Antifungal
        • Anti-parasitic
        • Anti-viral
      • By End User:
        • Pharmaceutical and Biotechnology Companies
        • Contract Research Organizations
        • Hospitals
        • Pathology/Diagnostic Laboratories
    • Africa
      • By Country/Region:
        • South Africa
        • Central Africa
        • North Africa
      • By Product Type:
        • Consumables
        • Instruments    
      • By Detection Methods:
        • Turbidimetric
        • Colorimetric
      • By Application:
        • Antibacterial
          • Tuberculosis
          • Sepsis
        • Antifungal
        • Anti-parasitic
        • Anti-viral
      • By End User:
        • Pharmaceutical and Biotechnology Companies
        • Contract Research Organizations
        • Hospitals
        • Pathology/Diagnostic Laboratories
  • Company Profiles
    • bioMérieux S.A.*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Strategies
    • HiMedia Laboratories
    • Alifax Holding S.p.A.
    • Creative Diagnostics
    • Resistell AG
    • Danaher Corporation
    • Becton, Dickinson and Company
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • Bio-Rad Laboratories, Inc.

 “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Overview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Product Type
      • Market Snippet, By Detection Method
      • Market Snippet, By Application
      • Market Snippet, By End User
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Market Trends
    • Key Developments
    • Regulatory Landscape
    • Product Recall
    • Epidemiology Analysis
    • Technology Overview
    • PEST Analysis
    • Porter’s Five Forces model
  4. Global Automated Antimicrobial Susceptibility Testing Market, By Product Type, 2018 – 2026, (US$ Million)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017 – 2026
      • Segment Trends
    • Consumables
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
    • Instruments
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
  5. Global Automated Antimicrobial Susceptibility Testing Market, By Detection Method, 2018 – 2026, (US$ Million)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017 – 2026
      • Segment Trends
    • Turbidimetric
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
    • Colorimetric
      • Introduction  
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
  6. Global Automated Antimicrobial Susceptibility Testing Market, By Application, 2018 – 2026, (US$ Million)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017 – 2026
      • Segment Trends
    • Antibacterial
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
        • Tuberculosis
        • Sepsis
    • Antifungal
      • Introduction  
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
    • Anti-parasitic
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
    • Anti-viral
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
  7. Global Automated Antimicrobial Susceptibility Testing Market, By End User, 2018 – 2026, (US$ Million)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017 – 2026
      • Segment Trends
    • Pharmaceutical and Biotechnology Companies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
    • Contract Research Organizations
      • Introduction  
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
    • Hospitals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
    • Pathology/Diagnostic Laboratories
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
  8. Global Automated Antimicrobial Susceptibility Testing Market, By Region, 2018 – 2026, (US$ Million)
    • Introduction
      • Market Share Analysis, By Region, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, By Region, 2017 – 2026
      • Regional Trends
    • North America
      • Market Size and Forecast, By Product Type, 2018 – 2026, (US$ Million)
      • Market Size and Forecast, By Detection Method, 2018 – 2026, (US$ Million)
      • Market Size and Forecast, By Application, 2018 – 2026, (US$ Million)
      • Market Size and Forecast, By End User, 2018 – 2026, (US$ Million)
      • Market Size and Forecast, By Country, 2018 – 2026, (US$ Million)
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast, By Product Type, 2018 – 2026, (US$ Million)
      • Market Size and Forecast, By Detection Method, 2018 – 2026, (US$ Million)
      • Market Size and Forecast, By Application, 2018 – 2026, (US$ Million)
      • Market Size and Forecast, By End User, 2018 – 2026, (US$ Million)
      • Market Size and Forecast, By Country, 2018 – 2026, (US$ Million)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Product Type, 2018 – 2026, (US$ Million)
      • Market Size and Forecast, By Detection Method, 2018 – 2026, (US$ Million)
      • Market Size and Forecast, By Application, 2018 – 2026, (US$ Million)
      • Market Size and Forecast, By End User, 2018 – 2026, (US$ Million)
      • Market Size and Forecast, By Country, 2018 – 2026, (US$ Million)
        • China
        • Japan
        • India
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Market Size and Forecast, By Product Type, 2018 – 2026, (US$ Million)
      • Market Size and Forecast, By Detection Method, 2018 – 2026, (US$ Million)
      • Market Size and Forecast, By Application, 2018 – 2026, (US$ Million)
      • Market Size and Forecast, By End User, 2018 – 2026, (US$ Million)
      • Market Size and Forecast, By Country, 2018 – 2026, (US$ Million)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Africa
      • Market Size and Forecast, By Product Type, 2018 – 2026, (US$ Million)
      • Market Size and Forecast, By Detection Method, 2018 – 2026, (US$ Million)
      • Market Size and Forecast, By Application, 2018 – 2026, (US$ Million)
      • Market Size and Forecast, By End User, 2018 – 2026, (US$ Million)
      • Market Size and Forecast, By Country/Region, 2018 – 2026, (US$ Million)
        • North Africa
        • Central Africa
        • South Africa
    • Middle East
      • Market Size and Forecast, By Product Type, 2018 – 2026, (US$ Million)
      • Market Size and Forecast, By Detection Method, 2018 – 2026, (US$ Million)
      • Market Size and Forecast, By Application, 2018 – 2026, (US$ Million)
      • Market Size and Forecast, By End User, 2018 – 2026, (US$ Million)
      • Market Size and Forecast, By Country, 2018 – 2026, (US$ Million)
        • GCC Countries
        • Israel
        • Rest of Middle East
  9. Competitive Landscape
    • Company Profiles
      • bioMérieux S.A.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • HiMedia Laboratories
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Alifax Holding S.p.A.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Creative Diagnostics
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Resistell AG
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Danaher Corporation
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Becton, Dickinson and Company
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Thermo Fisher Scientific Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Merck KGaA
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Bio-Rad Laboratories, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
    • Analyst Views
  10. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 38 market data tables and 25 figures on "Automated Antimicrobial Susceptibility Testing Market” - Global forecast to 2026”

Choose License Type

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

[email protected]

Key Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.